Late bleb-related endophthalmitis after trabeculectomy with adjunctive 5-fluorouracil

Ophthalmology. 1991 Jul;98(7):1053-60. doi: 10.1016/s0161-6420(91)32177-8.

Abstract

The incidence of late-onset bleb-related endophthalmitis was evaluated retrospectively in 229 consecutive trabeculectomies performed with adjunctive 5-fluorouracil (5-FU) therapy. Mean follow-up was 23.7 +/- 16.3 months (range, 3 to 60 months). Thirteen eyes (5.7%) of 11 patients developed bleb-related endophthalmitis an average of 25.9 +/- 17.4 months (range, 5 to 58 months) after surgery. Infection occurred in 9 of 96 (9.4%) procedures performed from below and in 4 of 133 (3.0%) procedures performed superiorly (P = 0.05, Fisher's exact test). The relative risk of bleb-related endophthalmitis in trabeculectomy from below versus above is 4.0 after adjustment for age and sex (95% confidence interval = 1.1, 14.8). Trabeculectomy with adjunctive 5-FU performed from below carries an increased risk of late bleb-related infection. The incidence of late bleb-related endophthalmitis after 5-FU trabeculectomy appears to be higher than that for trabeculectomy without adjunctive 5-FU injections.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Anti-Bacterial Agents / therapeutic use
  • Child
  • Child, Preschool
  • Endophthalmitis / drug therapy
  • Endophthalmitis / etiology*
  • Eye Infections, Bacterial / drug therapy
  • Eye Infections, Bacterial / etiology
  • Female
  • Fluorouracil / therapeutic use*
  • Follow-Up Studies
  • Glaucoma / drug therapy
  • Glaucoma / surgery*
  • Humans
  • Incidence
  • Intraocular Pressure / drug effects
  • Male
  • Middle Aged
  • Retrospective Studies
  • Risk Factors
  • Trabeculectomy / adverse effects*
  • Visual Acuity / drug effects

Substances

  • Anti-Bacterial Agents
  • Fluorouracil